Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
SURMOUNT-1: the landmark trial This 72-week trial enrolled 2,539 adults with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with at least one weight-related comorbidity
Which industries will feel it
While both companies were offering compounded GLP-1s during the FDA-declared shortages, Ro stopped when the shortage ended and has instead inked partnerships with both Eli Lilly and Novo Nordisk to offer their GLP-1 drugs on the platform
Pharmacodynamics (Effect)This section has been translated automatically
US$ 22.69
US$ 29.78
US$ 27.61
US$ 25.91
US$ 29.66
